Brief description of study

The purpose of this study is to assess the effect of sacubitril/valsartan vs. valsartan on changes in NT-proBNP and outcomes, safety, and tolerability in patients with HFpEF who have been stabilized during hospitalization for acute decompensated heart failure and initiated in-hospital or within 30 days post-discharge.

Clinical Study Identifier: s19-00184 Identifier: NCT03988634
Principal Investigator: Shaline D Rao.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.